# 2024-07-23--医疗器械-澳华内镜-国产软镜龙头，旗舰机型引领新成长_page55_表公司盈利预测假设条件

|   | 2022 | 2023 | 2024E | 2025E | 2026E | 2027E | 2028E |
|---|-----|-----|------|------|------|------|------|
| 营业收入增长率 | 28.30% | 52.29% | 46.17% | 45.70% | 39.75% | 20.00% | 15.00% |
| 营业成本/营业收入 | - | - | 25.32% | 24.37% | 23.36% | 24.00% | 24.00% |
| 管理费用/营业收入 | - | - | 19.08% | 12.77% | 10.50% | 10.00% | 9.90% |
| 研发费用/营业收入 | - | - | 20.00% | 19.50% | 19.00% | 18.50% | 18.00% |
| 销售费用/销售收入 | - | - | 33.00% | 28.00% | 25.00% | 20.00% | - |
| 营业税及附加/营业收入 | - | - | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% |
| 所得税率 | - | - | 12.00% | 12.00% | 12.00% | 12.00% | 12.00% |
| 股利分配比率 | - | - | 10.00% | 10.00% | 10.00% | 20.00% | 20.00% |